FDA unveils 5-year action plan for neurodegenerative drugs

Jul 12, 2022

amyotrophic lateral sclerosis

There’s an urgent need to improve and extend the lives of patients with rare neurodegenerative diseases, and the FDA is hoping a new five-year

Source: FDA unveils 5-year action plan for neurodegenerative drugs | Fierce Biotech

Hire with SEC


Schedule a free consultation today to experience our innovative, industry-leading executive search and engineer recruiting hiring process firsthand.

"*" indicates required fields

This field is hidden when viewing the form
This field is hidden when viewing the form
This field is for validation purposes and should be left unchanged.

Pin It on Pinterest